Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer
Titel:
Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer
Auteur:
Peeters, M. Price, T.J. Cervantes, A. Sobrero, A.F. Ducreux, M. Hotko, Y. André, T. Chan, E. Lordick, F. Punt, C.J.A. Strickland, A.H. Wilson, G. Ciuleanu, T.E. Roman, L. Van Cutsem, E. Tian, Y. Sidhu, R.